SEC Form 4 · accession 0001104659-17-061562
RHYTHM PHARMACEUTICALS, INC. · RYTM
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Period of report
Oct 10, 2017
Accepted (ET)
Oct 10, 2017 · 4:06 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001649904
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common StockF1 | Oct 10, 2017 | C | 545,256 | — | A | 545,256 | D |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Series A Convertible Preferred StockF1 | — | Oct 10, 2017 | C | 5,000,000 | D | — | — | Common Stock | 545,256 | 0 | D |
Explanation of responses
- F1The Series A Convertible Preferred Stock converted into Common Stock on a 9.17-for-one basis upon the closing of the Issuer's initial public offering. The shares had no expiration date.